C4 Therapeutics Inc. (CCCC)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
3. 87
+0.16
+4.3127%
After Hours
$
+0.06 +1.5504% 3. 93
410.2M Market Cap
- P/E Ratio
- Div Yield
2.36M Volume
-1.85 Eps
$ 3.71
Previous Close 
Want to track CCCC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
CCCC Earnings Reports FAQ
What is the earnings per share (EPS) for CCCC?
The current EPS is -1.85.
What is the company's earnings growth rate?
C4 Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
C4 Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for C4 Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for CCCC at this time, as C4 Therapeutics Inc has no recent EPS data to calculate it.
